研究单位：[1]Luye Pharma Group Ltd.[2]Chinese PLA General Hospital Beijing,China[3]Xuanwu Hospital Capital Medical University Beijing,China[4]Shengjing Hospital of China Medical University Shenyang,China
研究目的：
This study is to evaluate the safety and tolerability and to characterize the pharmacokinetics of multiple ascending dose (MAD) of LY03003 following intramuscular injections.
